KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Sarepta Therapeutics (SRPT) over the last 10 years, with Q2 2025 value amounting to $1.89.

  • Sarepta Therapeutics' EPS (Weighted Average and Diluted) rose 260000.0% to $1.89 in Q2 2025 from the same period last year, while for Jun 2025 it was $3.86, marking a year-over-year increase of 376000.0%. This contributed to the annual value of $2.34 for FY2024, which is 14034.48% up from last year.
  • Latest data reveals that Sarepta Therapeutics reported EPS (Weighted Average and Diluted) of $1.89 as of Q2 2025, which was up 260000.0% from $1.56 recorded in Q4 2024.
  • Over the past 5 years, Sarepta Therapeutics' EPS (Weighted Average and Diluted) peaked at $1.89 during Q2 2025, and registered a low of -$2.94 during Q3 2022.
  • Its 5-year average for EPS (Weighted Average and Diluted) is -$0.46, with a median of -$0.46 in 2023.
  • In the last 5 years, Sarepta Therapeutics' EPS (Weighted Average and Diluted) tumbled by 39000.0% in 2022 and then soared by 260000.0% in 2025.
  • Over the past 5 years, Sarepta Therapeutics' EPS (Weighted Average and Diluted) (Quarter) stood at -$1.43 in 2021, then rose by 13.29% to -$1.24 in 2022, then skyrocketed by 161.29% to $0.76 in 2023, then skyrocketed by 105.26% to $1.56 in 2024, then grew by 21.15% to $1.89 in 2025.
  • Its EPS (Weighted Average and Diluted) was $1.89 in Q2 2025, compared to $1.56 in Q4 2024 and $0.34 in Q3 2024.